CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug after transplant may stop leukemia relapse
Disease control Recruiting nowThis early-phase trial tests a drug called revumenib given after a stem cell transplant for people with certain types of acute leukemia. The goal is to see if it is safe and can help prevent the cancer from returning. About 27 adults and children will take part, and the study wil…
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 17, 2026 05:09 UTC
-
New study tracks blood clotting risks in kids receiving leukemia treatment
Knowledge-focused Recruiting nowThis study is for children and young adults (ages 2-21.5) with acute lymphoblastic leukemia or lymphoma who are scheduled to receive a drug called calaspargase pegol. The goal is to understand how this drug changes the blood's ability to clot. Researchers will take blood samples …
Matched conditions: CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC